Artículos de revistas
Caution In The Interpretation Of Guidelines For Drug Treatment Of Epilepsy [cuidados Na Interpretação Dos Guias Para Tratamento Medicamentoso De Epilepsia]
Journal Of Epilepsy And Clinical Neurophysiology. , v. 14, n. SUPPL. 2, p. 12 - 19, 2008.
This article critically reviews the role of evidence-based medicine and its guidelines, from their logistic preparation to their interpretation. The strengths and weaknesses of the methodological points are presented, as well the reasons for the extreme popularity of the guidelines in developed countries. The review discusses the main foundations of the most cited guidelines and some recent large studies. Some of the final conclusions are that clinical experience is always an important factor to consider, even in the face of solid evidence, to achieve the best possible management of any particular patient.14SUPPL. 21219French, J.A., Kanner, A.M., Bautista, J., Efficacy and tolerability of the new antiepileptic drugs: I: Treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy and the American Epilepsy Society (2004) Neurology, 62, pp. 1252-1260French, J.A., Kanner, A.M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C.L., Theodore, W.H., Glauser, T.A., Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2004) Neurology, 62 (8), pp. 1261-1273Glauser, T., Ben-Menachem, E., Bourgeois, B., Cnaan, A., Chadwick, D., Guerreiro, C., Kalviainen, R., Tomson, T., ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes (2006) Epilepsia, 47 (7), pp. 1094-1120. , DOI 10.1111/j.1528-1167.2006.00585.xMarson, A.G., Al-Kharusi, A.M., Alwaidh, M., Appleton, R., Baker, G.A., Chadwick, D.W., Cramp, C., Williamson, P.R., The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: An unblinded randomised controlled trial (2007) Lancet, 369 (9566), pp. 1000-1015. , DOI 10.1016/S0140-6736(07)60460-7, PII S0140673607604607Marson, A.G., Al-Kharusi, A.M., Alwaidh, M., Appleton, R., Baker, G.A., Chadwick, D.W., Cramp, C., Williamson, P.R., The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: An unblinded randomised controlled trial (2007) Lancet, 369 (9566), pp. 1016-1026. , DOI 10.1016/S0140-6736(07)60461-9, PII S0140673607604619Sackett, D.L., Stranss, S.E., Richardson, W.S., (2000) Evidence Based Medicine. How to Practice and Reach EBM, , Edinburgh: Churchill LivingstoneGlasziou, P., Del Mar, C., Salisbury, J., (2003) Evidence-based Medicine Workbook. Finding and Applying the Best Research Evidence to Improve Patient Care, , London: BMJ Books, BMJ Publishing GroupDans, A.L., Dans, L.F., The need and means for evidence-based medicine in develping countries (2000) ACP J Club, 133 (10), pp. 11-12Liberati, A., Moja, L.P., Moschetti, I., Evidence-based medicine: Its contributions in the way we search, appraise and apply scientific information to patient care (2007) Evidence-Based Neurology. Management of Neurological Disorders, pp. 3-10. , Candelise L, Hughes R, Liberati A, Uitdehaag BM, Warlow C, eds. Blackwell Publishing. BMJ BooksMayer, D., (2004) Essential Evidence-based Medicine, , Cambridge: University PressDefinition of key terms (1990) Clinical Practice Guidelines: Directions for a New Program, pp. 33-51. , Institute of Medicine Field MJ, Lohr KN, eds. Washington, DC: National Academy PressCavalcante, A.B., Silva, E., Prática da medicina baseada em evidências: Acessando com eficiência bases de dados eletrônicas (2007) Einstein Educ Contin Saúde, 5 (4 PART 2), pp. 109-111Hirtz, D., Ashwal, S., Berg, A., Bettis, D., Camfield, C., Camfield, P., Crumrine, P., Shinnar, S., Practice parameter: Evaluating a first nonfebrile seizure in children: Report of the Quality Standards Subcommittee of the American Academy of Neurology, the Child Neurology Society, and the American Epilepsy Society (2000) Neurology, 55 (5), pp. 616-623Hirtz, D., Berg, A., Bettis, D., Camfield, C., Camfield, P., Crumrine, P., Gaillard, W.D., Shinnar, S., Practice parameter: Treatment of the child with a first unprovoked seizure: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society (2003) Neurology, 60 (2), pp. 166-175Engel Jr., J., Wiebe, S., French, J., Sperling, M., Williamson, P., Spencer, D., Gumnit, R., Enos, B., Practice parameter: Temporal lobe and localized neocortical resections for epilepsy - Report of the quality standards subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons (2003) Neurology, 60 (4), pp. 538-547Chen, D.K., So, Y.T., Fisher, R.S., Use of serum prolactin in diagnosing epileptic seizures (2005) Neurology, 65, pp. 668-675. , Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyHarden, C.L., Huff, J.S., Schwartz, T.H., Dubinsky, R.M., Zimmerman, R.D., Weinstein, S., Foltin, J.C., Theodore, W.H., Neuroimaging in the emergency patient presenting with seizure (an evidence-based review) (2007) Neurology, 69, pp. 1772-1780. , Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyKrumholz, D., Wiebe, S., Gronseth, G., Shinnar, S., Levisohn, P., Ting, T., Hopp, J., French, J., Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review) (2007) Neurology, 69, pp. 1996-2007. , Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyNewer Drugs for Epilepsy in Adults, , www.nice.org.uk/Docret.asp?d=110081, Accessed May 5, 2008. Newer drugs for epilepsy in children. 〈www.nice.org.uk/Docret.asp?d=113359〉. Accessed May 5, 2008Handbook for the Preparation of Explicit Evidence-based Clinical Practice Guidelines, , http://www.nzgg.org.nz/download/files/nzgg_guideline_handbook.pdf, New Zealand Guidelines Group Accessed on May 5, 2008Warlow, C., What to do when there is no evidence (2007) Evidence-Based Neurology. Management of Neurological Disorders, pp. 11-14. , Candelise L, Hughes R, Liberati A, Uitdehaag BM, Warlow C, eds. Blackwell Publishing. BMJ BooksDiagnosis and Management of Epilepsy in Adults. Guideline N. 70, , www.sign.ac.uk/guidelines/fulltext/70/index.htlm, Publication: April 2003Chadwick, D., Marson, T., Choosing a first drug treatment for epilepsy after SANAD: Randomized controlled trials, systematic reviews, guidelines and treating patients (2007) Epilepsia, 48 (7), pp. 1259-1263. , DOI 10.1111/j.1528-1167.2007.01086.xPanayatopoulos, C.P., Evidence-based Epileptology, Randomized Controlled Trials, and SANAD: A Critical Clinical View (2007) Epilepsia, 48, pp. 1268-1274Brodie, M.J., Perucca, E., Ryvlin, P., Ben-Menachem, E., Meencke, H.-J., Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy (2007) Neurology, 68 (6), pp. 402-408. , DOI 10.1212/01.wnl.0000252941.50833.4a, PII 0000611420070206000006